Martin Zenker

Martin Zenker

Auto-generated profile, based on publicly available information

Martin Zenker

Otto-von-Guericke-Universität Magdeburg

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
MTMarco Tartaglia
Marco Tartaglia
BGBruce D. Gelb
Bruce D. Gelb
MZMartin Zenker
Martin Zenker

6 December 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ICIon C Cirstea
Ion C Cirstea
KKKerstin Kutsche
Kerstin Kutsche
RDRadovan Dvorsky
Radovan Dvorsky
LGLothar Gremer
Lothar Gremer
CCClaudio Carta
Claudio Carta
MZMartin Zenker
Martin Zenker
Martin Zenker, Marco Tartaglia, Reza Ahmadian and colleagues report the identification of a restricted spectrum of NRAS mutations in individuals with Noonan syndrome. Functional testing revealed that the mutations confer enhanced stimulus-dependent MAPK activation. Noonan syndrome, a developmental disorder characterized by congenital heart defects, reduced growth, facial dysmorphism and variable cognitive deficits, is caused by constitutional dysregulation of the RAS-MAPK signaling pathway. Here we report that germline NRAS mutations conferring enhanced stimulus-dependent MAPK activation account for some cases of this disorder. These findings provide evidence for an obligate dependency on proper NRAS function in human development and growth.

6 February 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SLSvjetlana Lovric
Svjetlana Lovric
SGSara Goncalves
Sara Goncalves
HGHeon Yung Gee
Heon Yung Gee
BOBabak Oskouian
Babak Oskouian
HSHonnappa Srinivas
Honnappa Srinivas
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1Δ yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.

14 August 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DBDaniela Braun
Daniela Braun
JRJia Rao
Jia Rao
GMGeraldine Mollet
Geraldine Mollet
DSDavid Schapiro
David Schapiro
MDMarie-Claire Daugeron
Marie-Claire Daugeron
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt

15 June 2010 in Human Mutation
Verified
Journal Article
Open access
PDF file
VMVerena Matejas
Verena Matejas
BHBernward Hinkes
Bernward Hinkes
FAFaisal Alkandari
Faisal Alkandari
LALihadh Al-Gazali
Lihadh Al-Gazali
EAEllen Annexstad
Ellen Annexstad
MZMartin Zenker
Martin Zenker
Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants. LAMB2 encodes the basement membrane protein laminin β2, which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease‐causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin β2 function is the molecular basis of Pierson syndrome. Although truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the N‐terminal LN domain, which is important for intermolecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist. Hum Mutat 31:992–1002, 2010.

8 February 2023 in Nature
Verified
Journal Article
Open access
PDF file
MMMartin A. Mensah
Martin A. Mensah
HNHenri Niskanen
Henri Niskanen
AMAlexandre P. Magalhaes
Alexandre P. Magalhaes
SBShaon Basu
Shaon Basu
MKMartin Kircher
Martin Kircher
DHDenes Hnisz
Denes Hnisz
Thousands of genetic variants in protein-coding genes have been linked to disease. However, the functional impact of most variants is unknown as they occur within intrinsically disordered protein regions that have poorly defined functions 1–3 . Intrinsically disordered regions can mediate phase separation and the formation of biomolecular condensates, such as the nucleolus 4,5 . This suggests that mutations in disordered proteins may alter condensate properties and function 6–8 . Here we show that a subset of disease-associated variants in disordered regions alter phase separation, cause mispartitioning into the nucleolus and disrupt nucleolar function. We discover de novo frameshift variants in HMGB1 that cause brachyphalangy, polydactyly and tibial aplasia syndrome, a rare complex malformation syndrome. The frameshifts replace the intrinsically disordered acidic tail of HMGB1 with an arginine-rich basic tail. The mutant tail alters HMGB1 phase separation, enhances its partitioning into the nucleolus and causes nucleolar dysfunction. We built a catalogue of more than 200,000 variants in disordered carboxy-terminal tails and identified more than 600 frameshifts that create arginine-rich basic tails in transcription factors and other proteins. For 12 out of the 13 disease-associated variants tested, the mutation enhanced partitioning into the nucleolus, and several variants altered rRNA biogenesis. These data identify the cause of a rare complex syndrome and suggest that a large number of genetic variants may dysregulate nucleoli and other biomolecular condensates in humans.